
Rashtriya Chemicals (RCF) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
37.3B
Gross Profit
17.1B
45.91%
Operating Income
1.0B
2.69%
Net Income
724.6M
1.94%
Balance Sheet Metrics
Total Assets
112.7B
Total Liabilities
65.2B
Shareholders Equity
47.5B
Debt to Equity
1.37
Cash Flow Metrics
Revenue & Profitability Trend
Rashtriya Chemicals Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 169.3B | 64.2B | 78.2B | 53.1B | 37.8B |
Cost of Goods Sold | 102.8B | 101.3B | 121.4B | 63.5B | 37.3B |
Gross Profit | 66.5B | -37.1B | -43.2B | -10.4B | 509.8M |
Gross Margin % | 39.3% | -57.7% | -55.3% | -19.5% | 1.3% |
Operating Expenses | |||||
Research & Development | - | 67.0M | 62.3M | 49.2M | 23.0M |
Selling, General & Administrative | 8.9B | 9.4B | 7.8B | 7.0B | 7.0B |
Other Operating Expenses | 44.9B | 48.4B | 62.6B | 41.1B | 25.4B |
Total Operating Expenses | 53.8B | 57.8B | 70.4B | 48.2B | 32.4B |
Operating Income | 4.1B | 3.1B | 13.9B | 8.3B | 5.8B |
Operating Margin % | 2.4% | 4.8% | 17.8% | 15.5% | 15.4% |
Non-Operating Items | |||||
Interest Income | - | 511.7M | 234.1M | 512.5M | 306.6M |
Interest Expense | 2.5B | 1.8B | 1.8B | 1.1B | 1.7B |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 3.3B | 3.0B | 12.7B | 9.4B | 5.3B |
Income Tax | 858.7M | 758.9M | 3.1B | 2.4B | 1.5B |
Effective Tax Rate % | 26.2% | 25.2% | 24.1% | 25.4% | 27.5% |
Net Income | 2.4B | 2.3B | 9.7B | 7.0B | 3.8B |
Net Margin % | 1.4% | 3.5% | 12.4% | 13.2% | 10.2% |
Key Metrics | |||||
EBITDA | 8.4B | 6.8B | 15.7B | 11.0B | 8.8B |
EPS (Basic) | ₹4.39 | ₹4.08 | ₹17.52 | ₹12.73 | ₹6.96 |
EPS (Diluted) | ₹4.39 | ₹4.08 | ₹17.52 | ₹12.73 | ₹6.96 |
Basic Shares Outstanding | 552277904 | 551688100 | 551688100 | 551688100 | 551688100 |
Diluted Shares Outstanding | 552277904 | 551688100 | 551688100 | 551688100 | 551688100 |
Income Statement Trend
Rashtriya Chemicals Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 9.9B | 1.6B | 113.0M | 11.0B | 14.7B |
Short-term Investments | 2.1B | 4.6B | 2.0B | 80.4M | 3.5B |
Accounts Receivable | 31.0B | 35.5B | 26.1B | 30.3B | 14.5B |
Inventory | 15.9B | 25.8B | 25.9B | 23.3B | 7.9B |
Other Current Assets | 3.5B | 3.0B | 200.0K | 6.9M | 1.1M |
Total Current Assets | 62.4B | 70.6B | 56.5B | 67.6B | 42.1B |
Non-Current Assets | |||||
Property, Plant & Equipment | 29.0B | 1.4B | 1.3B | 1.2B | 1.2B |
Goodwill | 5.7M | 300.0K | 4.3M | 16.0M | 29.8M |
Intangible Assets | - | 300.0K | 4.3M | 16.0M | 29.8M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 4.5B | 500.0K | 3.0B | 1.9B | 1.9B |
Total Non-Current Assets | 50.3B | 44.0B | 40.6B | 37.7B | 34.3B |
Total Assets | 112.7B | 114.6B | 97.0B | 105.3B | 76.4B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 22.2B | 19.5B | 20.2B | 23.6B | 9.2B |
Short-term Debt | 18.3B | 23.5B | 8.3B | 18.5B | 10.3B |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 1.0B | 166.2M | 167.0M | 192.3M | 39.2M |
Total Current Liabilities | 50.0B | 53.2B | 35.8B | 50.5B | 25.6B |
Non-Current Liabilities | |||||
Long-term Debt | 9.3B | 9.5B | 10.4B | 11.3B | 10.5B |
Deferred Tax Liabilities | 3.0B | 3.1B | 2.4B | 2.1B | 2.2B |
Other Non-Current Liabilities | 202.3M | 4.1M | 10.1M | 15.3M | 22.8M |
Total Non-Current Liabilities | 15.2B | 15.3B | 15.3B | 16.0B | 17.3B |
Total Liabilities | 65.2B | 68.5B | 51.1B | 66.5B | 42.9B |
Equity | |||||
Common Stock | 5.5B | 5.5B | 5.5B | 5.5B | 5.5B |
Retained Earnings | - | 0 | 0 | 0 | 0 |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 47.5B | 46.1B | 45.9B | 38.8B | 33.5B |
Key Metrics | |||||
Total Debt | 27.6B | 33.0B | 18.8B | 29.8B | 20.8B |
Working Capital | 12.3B | 17.4B | 20.7B | 17.1B | 16.5B |
Balance Sheet Composition
Rashtriya Chemicals Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 3.3B | 3.0B | 12.7B | 9.4B | 5.3B |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | 15.6B | -11.4B | -778.8M | -29.0B | 45.4B |
Operating Cash Flow | 20.5B | -7.8B | 12.4B | -20.3B | 52.0B |
Investing Activities | |||||
Capital Expenditures | -8.3B | -4.8B | -3.8B | -1.6B | -2.4B |
Acquisitions | -966.7M | - | 0 | -2.7B | -3.8B |
Investment Purchases | -54.8B | -52.9B | -44.4B | -85.9B | -29.1B |
Investment Sales | 54.9B | 53.0B | 44.5B | 85.9B | 29.1B |
Investing Cash Flow | -7.3B | -5.8B | -3.3B | -4.1B | -6.3B |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -684.1M | -2.0B | -2.3B | -1.7B | -2.2B |
Debt Issuance | 6.0B | 4.4B | 0 | 6.4B | 8.5B |
Debt Repayment | -4.5B | -1.8B | -2.3B | -5.3B | -3.5B |
Financing Cash Flow | -6.1B | 12.2B | -13.3B | 7.2B | -29.7B |
Free Cash Flow | 15.4B | -9.0B | 4.0B | -7.6B | 49.7B |
Net Change in Cash | 7.2B | -1.4B | -4.2B | -17.2B | 16.0B |
Cash Flow Trend
Rashtriya Chemicals Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
33.42
Forward P/E
19.83
Price to Book
1.71
Price to Sales
0.48
PEG Ratio
19.83
Profitability Ratios
Profit Margin
1.43%
Operating Margin
2.69%
Return on Equity
5.19%
Return on Assets
2.27%
Financial Health
Current Ratio
1.25
Debt to Equity
58.21
Beta
0.38
Per Share Data
EPS (TTM)
₹4.39
Book Value per Share
₹85.79
Revenue per Share
₹306.61
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
rcf | 81.0B | 33.42 | 1.71 | 5.19% | 1.43% | 58.21 |
Coromandel | 712.9B | 31.54 | 6.42 | 18.41% | 8.56% | 6.95 |
UPL | 622.8B | 3.00 | 1.63 | 2.01% | 0.09% | 105.06 |
EID Parry India | 194.3B | 18.85 | 2.44 | 14.68% | 2.78% | 20.91 |
Paradeep Phosphates | 183.0B | 22.86 | 4.50 | 13.53% | 5.28% | 106.91 |
Sharda Cropchem | 89.4B | 21.28 | 3.57 | 12.17% | 9.29% | 0.47 |
Financial data is updated regularly. All figures are in the company's reporting currency.